BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 28214218)

  • 21. Downregulation of miRNA-126-3p is associated with progression of and poor prognosis for lung squamous cell carcinoma.
    Chen SW; Lu HP; Chen G; Yang J; Huang WY; Wang XM; Huang SP; Gao L; Liu J; Fu ZW; Chen P; Zhai GQ; Luo J; Li XJ; Huang ZG; Li ZY; Gan TQ; Yang DP; Mo WJ; Zhou HF
    FEBS Open Bio; 2020 Aug; 10(8):1624-1641. PubMed ID: 32598517
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of DNA methylation regulation of miR-130b expression in human lung cancer using bioinformatics analysis.
    Wang J; Yu XF; OUYang N; Luo Q; Tong J; Chen T; Li J
    J Toxicol Environ Health A; 2019; 82(17):935-943. PubMed ID: 31524549
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bioinformatics analysis of differentially expressed miRNAs in non-small cell lung cancer.
    Yu H; Pang Z; Li G; Gu T
    J Clin Lab Anal; 2021 Feb; 35(2):e23588. PubMed ID: 32965722
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multiple mutations of lung squamous cell carcinoma shared common mechanisms.
    Li Q; Hou J; Hu Z; Gu B; Shi Y
    Oncotarget; 2016 Nov; 7(48):79629-79636. PubMed ID: 27835590
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MiR-375: A prospective regulator in medullary thyroid cancer based on microarray data and bioinformatics analyses.
    Shi L; Zhao SM; Luo Y; Zhang AW; Wei LH; Xie ZY; Li YY; Ma W
    Pathol Res Pract; 2017 Nov; 213(11):1344-1354. PubMed ID: 29033189
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oral squamous cell carcinoma: microRNA expression profiling and integrative analyses for elucidation of tumourigenesis mechanism.
    Manikandan M; Deva Magendhra Rao AK; Arunkumar G; Manickavasagam M; Rajkumar KS; Rajaraman R; Munirajan AK
    Mol Cancer; 2016 Apr; 15():28. PubMed ID: 27056547
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical Value and Potential Mechanism of miRNA-33a-5p in Lung Squamous Cell Carcinoma.
    Wang XM; Chen SW; Chen G; Zhou HF; Gan TQ; Zeng JJ; Li ZY
    Anal Cell Pathol (Amst); 2021; 2021():6614331. PubMed ID: 34888137
    [TBL] [Abstract][Full Text] [Related]  

  • 28. LINC01936 inhibits the proliferation and metastasis of lung squamous cell carcinoma probably by EMT signaling and immune infiltration.
    Tian Q; Liu X; Li A; Wu H; Xie Y; Zhang H; Wu F; Chen Y; Bai C; Zhang X
    PeerJ; 2023; 11():e16447. PubMed ID: 38084139
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Validation and target gene screening of hsa-miR-205 in lung squamous cell carcinoma.
    Huang W; Jin Y; Yuan Y; Bai C; Wu Y; Zhu H; Lu S
    Chin Med J (Engl); 2014; 127(2):272-8. PubMed ID: 24438615
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MicroRNAs associated with lung squamous cell carcinoma: New prognostic biomarkers and therapeutic targets.
    Qi L; Gao C; Feng F; Zhang T; Yao Y; Wang X; Liu C; Li J; Li J; Sun C
    J Cell Biochem; 2019 Nov; 120(11):18956-18966. PubMed ID: 31241205
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Exostosin1 as a novel prognostic and predictive biomarker for squamous cell lung carcinoma: A study based on bioinformatics analysis.
    Wu D; Huo C; Jiang S; Huang Y; Fang X; Liu J; Yang M; Ren J; Xu B; Liu Y
    Cancer Med; 2021 Apr; 10(8):2787-2801. PubMed ID: 33314711
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The expression, significance and function of cancer susceptibility candidate 9 in lung squamous cell carcinoma: A bioinformatics and in vitro investigation.
    Gao L; Guo YN; Zeng JH; Ma FC; Luo J; Zhu HW; Xia S; Wei KL; Chen G
    Int J Oncol; 2019 May; 54(5):1651-1664. PubMed ID: 30896821
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of crucial regulatory relationships between long non-coding RNAs and protein-coding genes in lung squamous cell carcinoma.
    Wu X; Ruan L; Yang Y; Mei Q
    Mol Cell Probes; 2016 Jun; 30(3):146-52. PubMed ID: 26928440
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical significance of miRNA‑1 and its potential target gene network in lung squamous cell carcinoma.
    Li X; Qin M; Huang J; Ma J; Hu X
    Mol Med Rep; 2019 Jun; 19(6):5063-5078. PubMed ID: 31059033
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aberrant miR-181b-5p and miR-486-5p expression in serum and tissue of non-small cell lung cancer.
    Tian F; Shen Y; Chen Z; Li R; Lu J; Ge Q
    Gene; 2016 Oct; 591(2):338-43. PubMed ID: 27291819
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transcriptomic and functional network features of lung squamous cell carcinoma through integrative analysis of GEO and TCGA data.
    Li Y; Gu J; Xu F; Zhu Q; Ge D; Lu C
    Sci Rep; 2018 Oct; 8(1):15834. PubMed ID: 30367091
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Integrative microRNA and gene profiling data analysis reveals novel biomarkers and mechanisms for lung cancer.
    Hu L; Ai J; Long H; Liu W; Wang X; Zuo Y; Li Y; Wu Q; Deng Y
    Oncotarget; 2016 Feb; 7(8):8441-54. PubMed ID: 26870998
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical significance of high expression of miR-452-5p in lung squamous cell carcinoma.
    Gan XN; Gan TQ; He RQ; Luo J; Tang RX; Wang HL; Zhou H; Qing H; Ma J; Hu XH; Chen G
    Oncol Lett; 2018 May; 15(5):6418-6430. PubMed ID: 29616113
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Upregulation of HOXA13 as a potential tumorigenesis and progression promoter of LUSC based on qRT-PCR and bioinformatics.
    Zhang R; Deng Y; Zhang Y; Zhai GQ; He RQ; Hu XH; Wei DM; Feng ZB; Chen G
    Int J Clin Exp Pathol; 2017; 10(10):10650-10665. PubMed ID: 31966409
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Exploration of the Perturbation of PKIG in Lung Squamous Cell Carcinoma and the Role in Tumor Microenvironment Based on Bioinformatics Method].
    Liu Q; Li H; Li B; Ren M; Li Z; Chen Y; Zheng Z; Meng Y; Feng H
    Zhongguo Fei Ai Za Zhi; 2023 Jul; 26(7):523-537. PubMed ID: 37653016
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.